早乙女迅雷

<form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>

<address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

Passive Biotech Equities

First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE? Arca? Biotechnology Index Fund (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the NYSE? Arca? Biotechnology Index (the “Index”).

$174.67

Compare similar ETFs

Fund Size

Dividend

Fees

NYSE Arca Biotechnology Index Fund FBT

Total Stock Market Index Fund VTSAX

Total Stock Market Index Fund VTI

500 Index Fund VFIAX

500 Index Fund VOO

View 1315 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$31.7B
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	0.27 %
Beta Indicates the relationship between the price performance of a share and the market.	0.6749
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	29.02
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-125.25
Profitable Companies	71
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	155.53
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	7.27
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	20.96

Compare to
Market

Enterprise Value to EBIT Enterprise Value divided by EBIT	2.22
Enterprise Value to Revenue Enterprise value divided by revenue	7.04
Total Debt to Enterprise Value Total debt divided by enterprise value	0.08
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	NaN
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	12.49%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	-
Return on Equity Equity divided by market cap.	82.14%
Return on Assets Indicates a company's profitability in relation to its total assets.	60.59%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	71.75%

Industries

Healthcare	93.8%
N/A	6.3%

Market cap

Micro Cap	0%
Small Cap	2%
Mid Cap	29%
Large Cap	69%
Mega Cap	0%

32 Investments

P/E-Ratio

Total Investment

Weight

CORT - Manufacturing

Corcept Therapeutics Inc

Total Investment

BGNE - Manufacturing

BeiGene Ltd

Total Investment

ITCI - Manufacturing

Intra-Cellular Therapies Inc

Total Investment

GILD - Manufacturing

Gilead Sciences Inc

Total Investment

HALO - Manufacturing

Halozyme Therapeutics Inc

Total Investment

AMGN - Manufacturing

Amgen Inc

Total Investment

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

Total Investment

ALKS - Manufacturing

Alkermes PLC

Total Investment

ALNY - Manufacturing

Alnylam Pharmaceuticals Inc

Total Investment

BMRN - Manufacturing

BioMarin Pharmaceutical Inc

Total Investment

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

Total Investment

MTD - Manufacturing

Mettler-Toledo International I

Total Investment

WAT - Manufacturing

Waters Corp

Total Investment

ACAD - Manufacturing

ACADIA Pharmaceuticals Inc

Total Investment

BIIB - Manufacturing

Biogen Inc

Total Investment

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

Total Investment

ARGX - Manufacturing

Argenx SE

Total Investment

GMAB - Professional, Scientific, and Technical Services

Genmab A/S

Total Investment

INCY - Professional, Scientific, and Technical Services

Incyte Corp

Total Investment

UTHR - Manufacturing

United Therapeutics Corp

Total Investment

RGEN - Manufacturing

Repligen Corp

Total Investment

NTRA - Health Care and Social Assistance

Natera Inc

Total Investment

NBIX - Manufacturing

Neurocrine Biosciences Inc

Total Investment

EXAS - Professional, Scientific, and Technical Services

Exact Sciences Corp

Total Investment

BNTX - Manufacturing

BioNTech SE

Total Investment

HoME 早乙女迅雷